Talk:5-MeO-aMT: Difference between revisions

>Tracer
Chemistry, pharmacology
>LockPicker
panels
Line 1: Line 1:
{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}
{{headerpanel|{{Approval}}}}
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/5-MeO-aMT}}
{{SubstanceBox/5-MeO-aMT}}
Line 12: Line 14:


==Pharmacology==
==Pharmacology==
{{pharmacology}}
{{Further|Serotonergic psychedelic}}
{{Further|Serotonergic psychedelic}}
5-MeO-aMT's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive.
5-MeO-aMT's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive.
Line 142: Line 145:
|}
|}


==Legality==
==Legal status==
{{legalStub}}
{{legalStub}}


==See also==
==See also==
Line 168: Line 170:
[[Category:Entactogen]]
[[Category:Entactogen]]
[[Category:Stimulant]]
[[Category:Stimulant]]
[[Category:Approval]]
[[Category:Articles in talk page]]
[[Category:Proofread]]
[[Category:Proofread]]


Return to "5-MeO-aMT" page.